Qube Research & Technologies (QRT)’s Cullinan Therapeutics CGEM Stock Holding History
Bought
Maintained
Sold
Other funds holding CGEM
LCM
KCM
SL
Qube Research & Technologies (QRT)'s CGEM Position: Q3 2026 in Review
Qube Research & Technologies (QRT) sold out of Cullinan Therapeutics (CGEM) in Q3 2026, closing a stake of 19,936 shares — an estimated $363K sold.
Qube Research & Technologies (QRT) first reported a position in CGEM in Q4 2021 and held it in 11 quarters. The position peaked at $3.32M in Q2 2024. 182 funds tracked by Wall St. Rank hold CGEM as of Q3 2026.
- Qube Research & Technologies (QRT) reported no remaining Cullinan Therapeutics position as of Q3 2026 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 19,936 Cullinan Therapeutics shares in Q3 2026, an estimated $363K.
- Qube Research & Technologies (QRT) first reported a position in Cullinan Therapeutics in Q4 2021 and held it in 11 quarters.
- Qube Research & Technologies (QRT)'s Cullinan Therapeutics position peaked at $3.32M in Q2 2024.
- 182 funds tracked by Wall St. Rank held Cullinan Therapeutics as of Q3 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.